Kirk Szafranski
Director HEOR, EVERSANA Value & Evidence
专长:
Forecasting Activities, HEOR
Kirk Szafranski is a Director, HEOR in the Value & Evidence Division at EVERSANA.
Kirk Szafranski holds an M.Sc. in Laboratory Medicine and Pathobiology from the University of Toronto and has extensive experience with scientific research, data analysis and scientific communications. He has worked in a wide range of therapeutic areas including cardiovascular imaging, hemophilia, oncology, neurodegenerative disease, diabetes, schizophrenia and orphan diseases such as graft-versus-host disease. At EVERSANA, Kirk has written global value dossiers, developed cost-effectiveness models, prepared budget impact analyses, developed network meta-analyses and performed analyses on individual patient-level data.